Showing 13,661 - 13,680 results of 106,316 for search '(( a de decrease ) OR ( 5 ((((ng decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 1.33s Refine Results
  1. 13661

    Table_5_Genome-Wide Identification of Rare and Common Variants Driving Triglyceride Levels in a Nevada Population.xlsx by Robert W. Read (6248582)

    Published 2021
    “…The study identified 549 significant single-variant associations (p < 8.75 × 10<sup>–9</sup>), many in chromosome 11’s triglyceride hotspot: ZPR1, BUD13, APOC3, APOA5. A well-known protective loss-of-function variant in APOC3 (R19X) was associated with a 51% decrease in triglyceride levels in the cohort. …”
  2. 13662
  3. 13663
  4. 13664

    Table 5_Pan-cancer analysis of phagocytosis regulators in female-specific cancers: a focus on HMGB2.xlsx by Xiaoqin Lu (3121482)

    Published 2025
    “…High-frequency mutations were found in PTEN, ARID1A, and UBR4. Genes like COX5B and MS4A1 emerged as potential predictors of clinical outcomes and therapeutic response. …”
  5. 13665
  6. 13666
  7. 13667
  8. 13668

    Temporal Evaluation of Coronary Revascularization Procedures Performed through the Unified Health System (SUS) in Brazil: a 20-year overview by Igor Ribeiro de Castro Bienert (6125738)

    Published 2018
    “…Similarly, the number of primary angioplasties increased between 2004 and 2015 (from 1,901 to 8,524). There was a decrease in the mean length of hospital stay (from 14.4 to 12.8 days) and hospital mortality (from 7.6% to 5.9%) for surgical revascularizations, and decrease in mean length of hospital stay (from 5.3 days to 3.7 days) but maintenance of the mortality rates (2.2%) for percutaneous revascularizations. …”
  9. 13669
  10. 13670
  11. 13671
  12. 13672

    Table_3_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx by Sisi Shan (6738692)

    Published 2021
    “…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”
  13. 13673

    Table_2_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx by Sisi Shan (6738692)

    Published 2021
    “…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”
  14. 13674

    Image_1_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

    Published 2021
    “…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”
  15. 13675

    Table_5_Trichohyalin gene expression is negatively correlated with the severity of dermatitis in a canine atopic dermatitis model.XLSX by Rosanna Marsella (8606172)

    Published 2024
    “…Introduction<p>Canine atopic dermatitis (AD) closely mimics human AD and is recognized as a beneficial animal model. House dust mites (HDM) are a common allergen for both species. …”
  16. 13676

    Image_4_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

    Published 2021
    “…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”
  17. 13677

    Table_1_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx by Sisi Shan (6738692)

    Published 2021
    “…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”
  18. 13678

    Image_2_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

    Published 2021
    “…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”
  19. 13679

    Occupational risk factors for asthma exacerbation in adults: a five-year follow-up of the Norwegian Telemark study cohort by N Zivadinovic (21239948)

    Published 2025
    “…</p> <p><b><i>Methods:</i></b> In a prospective study of respiratory health in Telemark, Norway, 1857 adult participants with physician-diagnosed asthma were invited to participate in a follow-up survey. …”
  20. 13680

    5.HT<sub>1A</sub> binding difference between known cause of death (KCOD) controls and SIDS. by Hannah C. Kinney (10280975)

    Published 2025
    “…When SIDS is compared to all KCOD controls, the HG, NTS, and MAO show a significant mean difference in 5-HT<sub>1A</sub> receptor binding. …”